http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018216066-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8873f58ee1e725f7a79a6459bb2fa652
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2302
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0647
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0789
filingDate 2018-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2854c35deb4b872172115f700a7dd9e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9f33b8039f82d63376c919998cf6068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0ca256a8111094c24337d5bad1df686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50381fed240f4ab725fe6d1e6f75329a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5d0d930d445dbfb3c1e1ebd6afe3f08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bfeb2690c708a9ab9f3004da6d17f5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56644929e6a56b8d15fd36dfa7c6e579
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c15c313fa2a8711cea43be37fb883b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98e001b46a34d6d97d8ab44a89968036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11d23dca26ad626187eb263cf4aa8f8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65daa577719a98d61860604bd15a0440
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7036fd0f76f2bd800facfc1dff86db4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2255bdcf68883415daec5bca9beb39b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a67cf0d7ab41723fbf06f54a5c466f12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ffadae2f72524408ba6b5f16ab8b061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4597658d51c324d3efd9094ea2c16f20
publicationDate 2018-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2018216066-A1
titleOfInvention Methods for isolating and proliferating autologous cancer antigen-specific cd8+ t cells
abstract Provided is a method for isolating and proliferating autologous cancer antigen-specific CD8 + T cells, and more particularly, a method for selecting an epitope recognized by CD8 + T cells from autologous cancer antigens present in blood of individual cancer patients; and isolating autologous cancer antigen-specific CD8 + T cells by using a peptide of the selected epitope, and a method of massively proliferating CD8 + T cells by using the method. According to the present invention, it is possible to isolate autologous cancer antigen-specific CD8 + T cells by using the peptide of the CD8 T cell epitope of the autologous cancer antigen present in blood of individual cancer patients instead of a heterologous antigen. Therefore, by using T cells recognizing the autologous cancer antigen, it is possible to effectively select and eliminate cancer cells derived from the cancer patient's own cells. Thus, T cells can be applied to treatment and alleviation of cancer diseases without side effects.
priorityDate 2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830

Total number of triples: 34.